Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

tgAAC 09

Drug Profile

tgAAC 09

Alternative Names: Gag-PR-RT AAV HIV vaccine; HIV vaccine - Targeted Genetics; tgAAC-09

Latest Information Update: 11 Nov 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Targeted Genetics
  • Developer Columbus Childrens Hospital; International AIDS Vaccine Initiative; Targeted Genetics Corporation; The Childrens Hospital of Philadelphia
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 12 Mar 2007 Data presented at the 14th Conference on Retroviruses and Opportunistic Infections (CROI-2007) added to the adverse events and Viral Infections immunogenicity sections
  • 12 Mar 2007 Phase-I clinical trials in HIV infections prevention in European Union (IM)
  • 28 Jun 2006 Targeted Genetics and the International Aids Vaccine Initiative have extended their collaboration for the development of HIV/AIDS vaccines in the developing world
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top